KING OF PRUSSIA, Pa., Sept. 13, 2016
KING OF PRUSSIA, Pa., Sept. 13, 2016 /PRNewswire/ -- Imalogix has been awarded a group purchasing agreement for radiation dose tracking and analytics with Premier Inc. Effective July 1, 2016, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for an imaging and dose performance management solution.
"We are excited to offer Premier members access to the only company with a complete dose monitoring solution that is much more than just software. We are proud to be recognized by Premier for our innovations and can now bring solutions to the community that takes the complexities out of implementing a dose performance management program," says John Heil CEO of Imalogix.
Imalogix is an innovative cloud-based performance management and dose monitoring solution for the medical imaging community. Imalogix™ is the industry's only complete solution that offers built-in medical physicist support. Imalogix™ removes the roadblocks to achieving Joint Commission dose standards. Installation does not require hundreds of man-hours tied up in preparatory meetings, nor does it require a great amount of IT support. Once installed, Imalogix™ immediately begins to report dose metrics with no impact to departmental or patient workflow. Imalogix™ is more than just dose tracking—it enables actionable insights with a powerful dashboard to compare dose trends, identify outlier conditions and trend protocol performance across the healthcare enterprise with ease. Imalogix™ provides a scalable performance management solution designed to help customers discover gaps to systematically improve patient safety and lower dose.
Premier is a leading healthcare improvement company, uniting an alliance of approximately 3,750 U.S. hospitals and more than 130,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost.
About medInt Holdings, LLC d.b.a. Imalogix
Headquartered in King of Prussia, PA, medInt Holdings, LLC is a Healthcare IT company that integrates with the diagnostic and therapeutic disciplines, turning data into usable knowledge to improve patient safety, increase quality and save lives. Its flagship product, Imalogix™, helps you manage your risk by providing the industry's only enterprise platform to protect your imaging business, your patients, your providers and your margins. For more information, please visit www.imalogix.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/imalogix-awarded-dose-tracking-and-analytics-agreement-with-premier-inc-300325491.html
SOURCE ImalogixPR Newswire
Last updated on: 13/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.